BusinessCempra and Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement for SolithromycinBy Nasdaq OMXFeb 1, 2016, 12:30 PM UTC
BusinessCempra to Ring NASDAQ Closing Bell to Mark 10th AnniversaryBy Nasdaq OMXJan 26, 2016, 1:00 PM UTC
BusinessOtonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing LossBy Nasdaq OMXJan 26, 2016, 12:05 PM UTC
